Morepen Laboratories Q2 Results FY27: PAT Jumps 116.59% to Rs 88.89 Cr, Revenue Rs 746.50 Cr
- October 27, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Morepen Laboratories Q2 Results FY27 were declared on 27 October 2026, with consolidated revenue of Rs 746.50 Cr, up 81.37% YoY, and net profit of Rs 88.89 Cr, up 116.59% YoY. Operating Profit rose to Rs 123.12 Cr from Rs 30.69 Cr a year earlier. These quarterly results cover July to September 2026 and show YoY growth on all three lines. Univest sets out each figure in the sections below.
Morepen Laboratories Ltd (MOREPENLAB) Q2 Results FY27 announced on 27 October 2026, covering the company’s financial performance for the July to September quarter. The Morepen Laboratories Q2 Results FY27 filing reports consolidated revenue of Rs 746.50 Cr and net profit of Rs 88.89 Cr. The results date and the consolidated results basis apply to every number in this article, and all comparisons are made with the July to September 2025 quarter.
This Morepen Laboratories Q2 Results review is a results analysis of the filing, covering the financial highlights, the business factors, the outlook and the risks. Readers can compare the same figures with other companies in the Univest Screener, and the Financial Highlights table comes next.
Click Here – Get Free Investment Predictions
Morepen Laboratories Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 746.5 Cr | Rs 411.58 Cr | +81.37% YoY |
| Operating Profit | Rs 123.12 Cr | Rs 30.69 Cr | +301.17% YoY |
| Net Profit (PAT) | Rs 88.89 Cr | Rs 41.04 Cr | +116.59% YoY |
Source: company filing for Morepen Laboratories Q2 Results FY27, 27 October 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Morepen Laboratories Q2 Results: What Stands Out
- Revenue: Consolidated revenue reached Rs 746.50 Cr, up 81.37% from Rs 411.58 Cr in the same quarter of the previous year.
- Net profit: Net profit of Rs 88.89 Cr compares with Rs 41.04 Cr a year ago, a YoY growth rate of 116.59%.
- Operating Profit: Operating Profit rose 301.17% YoY to Rs 123.12 Cr, against Rs 30.69 Cr in the comparison quarter.
- Morepen Laboratories Q2 Results FY27: Operating Profit grew fastest, followed by net profit, with revenue showing the smallest percentage increase of the three lines.
- Next step: The performance analysis below compares these three moves before moving to the disclosed business factors.
Morepen Laboratories Q2 Results FY27: Performance Analysis
The Morepen Laboratories Q2 Results FY27 numbers show growth on every headline line. Revenue moved from Rs 411.58 Cr to Rs 746.50 Cr, Operating Profit from Rs 30.69 Cr to Rs 123.12 Cr, and net profit from Rs 41.04 Cr to Rs 88.89 Cr, each measured on a YoY basis.
In percentage terms, revenue rose 81.37%, net profit rose 116.59% and Operating Profit rose 301.17%. This results analysis therefore finds that profit lines expanded faster than revenue. Net profit margin improved to 11.9% from 10.0% in the comparison quarter, which is the clearest arithmetic link between revenue and profit.
Quarterly net profit has also ranged from Rs 15.75 Cr to Rs 88.89 Cr over the last 5 quarters, so readers of Morepen Laboratories Q2 Results will see the latest figure at the top of that range. The YoY growth numbers form the quarterly results core, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The results analysis starts with revenue, which grew 81.4% year on year to Rs 746.50 Cr in the latest quarter, the largest single driver of the headline figures in the July to September 2026 quarterly results.
Net Profit Growth – Net profit rose 116.6% year on year to Rs 88.89 Cr, and the margin improved to 11.9% from 10.0% in the comparison quarter, so profit grew faster than revenue in Morepen Laboratories Q2 Results FY27.
Consecutive Revenue Rise – Revenue has risen in each of the last 4 quarters, which places the 81.37% YoY gain inside a run of higher quarterly revenue. The disclosed data confirms the sequence but does not establish its cause.
FY27 Outlook After Morepen Laboratories Q2 Results
Full-year FY27 results for Morepen Laboratories will depend on the quarters still to be declared and on the sector conditions that are disclosed. This results analysis therefore treats the July to September 2026 quarter as one input to the year, without projecting any figure beyond what has been reported.
Investors can use later declarations to see how net profit compares with the Rs 15.75 Cr to Rs 88.89 Cr range of the last 5 quarters, and whether revenue keeps rising after the 81.37% YoY gain in Morepen Laboratories Q2 Results FY27. The risks below list the points to watch.
Key Risks to Watch After Morepen Laboratories Q2 Results FY27
Low Return on Equity
Return on equity was low at 7.96% in FY26. Morepen Laboratories Q2 Results FY27 show YoY growth on all three lines, but the full-year return on equity is a separate measure that readers should keep in view.
Profit Per Share Trend
Annual profit on a per-share basis has slipped between FY22 and FY26, so the YoY growth in this quarter sits against a longer record that is lower than it was four years earlier.
Volatile Quarterly Profit
Quarterly net profit has been volatile, ranging from Rs 15.75 Cr to Rs 88.89 Cr over the last 5 quarters. A wide range means one quarter should be read alongside the others rather than alone.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Morepen Laboratories Q2 Results FY27 describe a quarter in which consolidated revenue rose 81.37% YoY to Rs 746.50 Cr and net profit rose 116.59% to Rs 88.89 Cr. Read with the earlier quarterly results and the consolidated results basis, the figures give a full YoY picture. Anyone studying Morepen Laboratories Q2 Results should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Morepen Laboratories Q2 Results FY27
What are Morepen Laboratories Q2 Results FY27?
Ans. Morepen Laboratories Q2 Results FY27 are the consolidated results for July to September 2026, showing revenue of Rs 746.50 Cr and net profit of Rs 88.89 Cr, as laid out in the Financial Highlights table of this article.
What is the results date for Morepen Laboratories Q2 Results FY27?
Ans. Morepen Laboratories declared its Q2 FY27 results on 27 October 2026, so the results date covers the July to September 2026 quarter, as the opening section of this results analysis explains.
What revenue was reported in Morepen Laboratories Q2 Results FY27?
Ans. Morepen Laboratories reported consolidated revenue of Rs 746.50 Cr in Q2 FY27 against Rs 411.58 Cr a year earlier, which means revenue is up 81.37% YoY, as the Performance Analysis shows.
What net profit was reported in Morepen Laboratories Q2 Results FY27?
Ans. The company reported net profit of Rs 88.89 Cr for the quarter against Rs 41.04 Cr in the same quarter last year, which means net profit is up 116.59% YoY, as the Key Takeaways section shows.
How much YoY growth did revenue show in Morepen Laboratories Q2 Results FY27?
Ans. Revenue showed YoY growth of 81.37%, moving from Rs 411.58 Cr to Rs 746.50 Cr, while Operating Profit grew 301.17%, as the Performance Analysis section sets out.
Did net profit rise or fall in Morepen Laboratories Q2 Results?
Ans. Net profit rose in Morepen Laboratories Q2 Results, from Rs 41.04 Cr to Rs 88.89 Cr, an increase of 116.59%, alongside a net profit margin of 11.9% against 10.0% a year ago, as the Performance Analysis explains.
What was the Operating Profit in Morepen Laboratories Q2 Results FY27?
Ans. Operating Profit was Rs 123.12 Cr, up 301.17% from Rs 30.69 Cr a year earlier, so it grew faster than both revenue and net profit, as the Key Takeaways section notes.
Are Morepen Laboratories Q2 Results consolidated results or standalone results?
Ans. The company reported on a consolidated basis, so the figures represent the consolidated results. Alongside this, every number in the Financial Highlights table follows that same basis.
What business factors shaped Morepen Laboratories Q2 Results FY27?
Ans. The disclosed factors are the 81.4% revenue growth, the 116.6% net profit rise and revenue gains in each of the last 4 quarters, as covered in the Key Business Factors section.
What are the key risks after Morepen Laboratories Q2 Results FY27?
Ans. The risks are a low 7.96% return on equity in FY26, a lower annual profit per share than in FY22 and a wide quarterly net profit range, as the Key Risks section details.
What is the outlook after Morepen Laboratories Q2 Results?
Ans. The outlook after Morepen Laboratories Q2 Results rests on later quarters of FY27, since full-year net profit will depend on those declarations, so this results analysis treats the quarter as one input, as the Outlook section explains.
Where can I find the complete Morepen Laboratories Q2 Results FY27 data?
Ans. The complete Morepen Laboratories Q2 Results FY27 data is in the Financial Highlights table above, while the Univest Screener and the Univest app carry further figures, as noted in the closing sections of this article.
